Nama Chemicals Company (2210.SR)
SAR 27.0
(0.56%)
SAR 27.0
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -22.95 Million | 64.49 Million | 93.78 Million | 27.64 Million | 71.06 Million | 95.52 Million |
| Net Income | -152.43 Million | 39.5 Million | 31.48 Million | -41.09 Million | 10.08 Million | 35.27 Million |
| Depreciation & Amortization | 62.23 Million | 67.46 Million | 61.33 Million | 58 Million | 56.95 Million | 55.62 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 47.78 Million | -47.69 Million | 35.22 Million | 16.07 Million | 6.44 Million | -12.35 Million |
| Other non-cash items | 19.46 Million | 5.21 Million | -34.25 Million | -5.34 Million | -2.42 Million | 60.24 Million |
| Investing Cash Flow | -6.58 Million | -8.37 Million | 137.01 Million | -6.75 Million | -8.32 Million | -476 Thousand |
| Investments in PPE | -10.06 Million | -8.37 Million | -15.99 Million | -7.23 Million | -8.76 Million | -12.5 Million |
| Acquisitions | 4.11 Million | - | 1.61 Million | 484 Thousand | 438 Thousand | - |
| Investment purchases | - | - | -1.61 Million | - | - | - |
| Sales/Maturities of investments | - | - | 145.87 Million | - | - | - |
| Other Investing Activities | 3.48 Million | - | 7.12 Million | 12.28 Million | 438 Thousand | -476 Thousand |
| Financing Cash Flow | 34.79 Million | -57.05 Million | -226.67 Million | -39.14 Million | -57.73 Million | -104.22 Million |
| Debt repayment | -4.64 Million | -63.93 Million | -184.09 Million | -50.32 Million | -57.73 Million | -104.22 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 5.91 Million | - | - | - |
| Other Financing Activities | 30.14 Million | 6.88 Million | -48.49 Million | 11.17 Million | -60.11 Million | -104.22 Million |
| Accounts receivables | 35.31 Million | -5.83 Million | -26.42 Million | 1.81 Million | 17.89 Million | -37 Thousand |
| Accounts payables | -12.04 Million | -37.12 Million | 95.67 Million | 34.3 Million | 7.98 Million | -11.95 Million |
| Inventory | 14.49 Million | -20.95 Million | -34.42 Million | -12.74 Million | 27.5 Million | -39.62 Million |
| Other working capital | -2.02 Million | 16.22 Million | 395 Thousand | -7.29 Million | -46.93 Million | 39.26 Million |
| Cash at beginning of period | 9.31 Million | 10.26 Million | 6.16 Million | 24.38 Million | 19.38 Million | 28.57 Million |
| Cash at end of period | 14.44 Million | 9.31 Million | 10.26 Million | 6.16 Million | 24.38 Million | 19.38 Million |
| Capital Expenditure | -10.06 Million | -8.37 Million | -15.99 Million | -7.23 Million | -8.76 Million | -12.5 Million |
| Effect of forex changes on cash | -127 Thousand | -12 Thousand | -28 Thousand | 40 Thousand | -3000.00 | -13 Thousand |
| Net cash flow / Change in cash | 5.12 Million | -946 Thousand | 4.1 Million | -18.21 Million | 4.99 Million | -9.18 Million |
| Free Cash Flow | -33.01 Million | 56.12 Million | 77.79 Million | 20.4 Million | 62.29 Million | 83.01 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 52.94 Million | -29.69 Million | -152.43 Million | -57.42 Million | -50.66 Million | -25.77 Million |
| Depreciation & Amortization | 14.09 Million | 14.94 Million | 64.18 Million | 17.69 Million | 15.85 Million | 15.3 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 18.15 Million | -11.02 Million | 32.74 Million | -13.26 Million | 50.23 Million | 22.27 Million |
| Other non-cash items | -87.19 Million | 51.68 Million | 116.28 Million | 56.89 Million | 1.17 Million | 915 Thousand |
| Investing Cash Flow | 1.75 Million | -6.37 Million | -6.58 Million | 4.31 Million | -8.93 Million | -1.33 Million |
| Investments in PPE | -4.33 Million | -6.37 Million | -10.7 Million | 195 Thousand | -8.93 Million | -1.33 Million |
| Acquisitions | 6.09 Million | - | 4.11 Million | 4.11 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 3.48 Million | 4.11 Million | -634 Thousand | - |
| Financing Cash Flow | 3.52 Million | 9.1 Million | 34.79 Million | 28.57 Million | -16.58 Million | 275 Thousand |
| Debt repayment | -3.52 Million | -11.05 Million | -39.9 Million | -29.52 Million | -4.02 Million | -21.29 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 15.07 Million | 15.41 Million | 30.14 Million | 28.47 Million | -12.56 Million | 21.56 Million |
| Accounts receivables | 7.96 Million | -2.99 Million | 42.19 Million | 17.11 Million | 43.87 Million | -12.49 Million |
| Accounts payables | 16.83 Million | 1.38 Million | -12.04 Million | -4.38 Million | -10.84 Million | 32.01 Million |
| Inventory | -461 Thousand | -6.75 Million | 14.49 Million | -9.87 Million | 13.93 Million | 2.42 Million |
| Other working capital | -6.17 Million | -2.65 Million | -11.88 Million | -16.11 Million | 3.26 Million | 331 Thousand |
| Cash at beginning of period | 4.96 Million | 14.44 Million | 9.31 Million | 10.25 Million | 19.16 Million | 7.56 Million |
| Cash at end of period | 4.38 Million | 4.96 Million | 14.44 Million | 14.44 Million | 10.25 Million | 19.16 Million |
| Capital Expenditure | -4.33 Million | -6.37 Million | -10.7 Million | 195 Thousand | -8.93 Million | -1.33 Million |
| Effect of forex changes on cash | -202 Thousand | 141 Thousand | -127 Thousand | -69 Thousand | 3000.00 | -63 Thousand |
| Net cash flow / Change in cash | -582 Thousand | -9.48 Million | 5.12 Million | 4.19 Million | -8.91 Million | 11.59 Million |
| Free Cash Flow | -10.2 Million | -18.73 Million | -33.65 Million | -28.43 Million | 7.67 Million | 11.38 Million |
MDALF
PRICOLLTD
CFT
1981
EMMA
004150